January 25th 2024
The expanded indication makes dupilumab the only approved treatment for eosinophilic esophagitis (EoE) in this age group.
Turning Food Allergy Triggers Into Therapy: A Managed Care Lens on Immunotherapy and Targeted Biologics
1.5 Credits / Immunology
View More
Targeted Therapies for the Management of Eosinophilic Esophagitis Across the Life Cycle: The Role of the Pharmacist in Patient Identification and Optimization, featuring a Pat...
1.5 Credits / Immunology
View More
Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment
1.5 Credits / Allergy, Immunology
View More
Dupilumab Meaningfully Reduces Symptoms for Patients With EoE, Study Finds
March 19th 2022Compared with placebo, dupilumab treatment resulted in statistically significant and meaningful symptom improvements in adults and adolescents with eosinophilic esophagitis (EoE), according to abstracts presenting findings from the 3-part LIBERTY-EoE-TREET study.
Read More
AstraZeneca Receives CRL for Benralizumab in Chronic Rhinosinusitis With Nasal Polyps
March 16th 2022FDA issued a complete response letter (CRL) to AstraZeneca seeking additional clinical data for benralizumab, sold as Fasenra, in the treatment of patients with inadequately controlled chronic rhinosinusitis with nasal polyps.
Read More
Incidence of Nasal Polyps Linked With Severe Radiographic Disease in CRS
March 13th 2022Patients with chronic rhinosinusitis (CRS) with severe radiographic disease were more likely to report incidence of nasal polyps and be managed by endoscopic sinus surgery, but did not show greater health care utilization.
Read More
Patients With CRSwNP, Comorbidities at Greater Risk for Revision Sinus Surgery
March 8th 2022Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who have comorbidities were more likely than those without co-occuring conditions to require revision endoscopic sinus surgery over a 10-year period.
Read More
EoE Studies Examine Early Life Influences, Alignment of Parent-Child Reports
March 2nd 2022Abstracts presented at a recent meeting of allergists and immunologists explored early factors in disease development of eosinophilic esophagitis (EoE) as well as symptoms reported by parents and children.
Read More
Novel Questionnaire Shows Promise in Determining HRQOL for CRS With Nasal Polyps
March 2nd 2022The nasal polyposis quality of life (NPQ) questionnaire was shown to be valid, reliable, and sensitive to individual changes in evaluating the health-related quality of life of patients with chronic rhinosinusitis with nasal polyps.
Read More
Second Phase 3 Trial Shows Dupilumab Improves EoE in Patients 12 and Older
February 26th 2022During the annual meeting of the American Academy of Allergy, Asthma and Immunology, presenters said findings from a second phase 3 trial of dupilumab for eosinophilic esophagitis (EoE) continued to show the biologic improved symptoms in adults and adolescents.
Read More
Postsurgery Factors Linked With Disease Control in Chronic Rhinosinusitis With Nasal Polyps
February 8th 2022Patients with chronic rhinosinusitis with nasal polyps who had elevated serum amyloid A (SAA) levels were more likely to achieve disease-controlled status vs those with low SAA levels after endoscopic sinus surgery.
Read More
Patients With EoE Have High Level of HCRU, Analysis Finds
February 5th 2022This retrospective study using administrative claims data examining health care resource utilization (HCRU) found that in the months before a diagnosis of eosinophilic esophagitis (EoE), other diseases were more commonly diagnosed.
Read More
Sinonasal CT Scores May Predict Prognostic Features of Chronic Rhinosinusitis With Nasal Polyps
February 2nd 2022Sinonasal CT scores were associated with several prognostic features in the disease course of chronic rhinosinusitis with nasal polyps, including blood eosinophil counts and risk of relapse after endoscopic sinus surgery.
Read More
Steroid-Eluting Implants May Reduce Health Care Utilization From Chronic Rhinosinusitis
January 28th 2022Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following endoscopic sinus surgery.
Read More
Endoscopic Sinus Surgery With Medical Therapy Effective for Chronic Rhinosinusitis With Nasal Polyps
January 22nd 2022Patients with chronic rhinosinusitis with nasal polyps were found to benefit more from the combination of endoscopic sinus surgery plus medical therapy vs medical therapy alone, although the minimal clinically important difference was not met.
Read More
Dr David R. Stukus on the Increase in Eosinophilic Esophagitis
January 6th 2022David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, talks about the increase of eosinophilic esophagitis, or EoE, along with other allergic conditions.
Watch